Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion

This report may broaden the application of Dara-Rd for POEMS syndrome.PMID:36202948 | DOI:10.1007/s12185-022-03459-w

Source: International Journal of Hematology - October 6, 2022 Category: Hematology Authors: Takashi Oyama Kazuki Taoka Akira Chiba Yosuke Masamoto Masako Ikemura Akira Honda Hiroaki Maki Mineo Kurokawa Source Type: research